More Post from the Author
- Cobre del Mayo, S.A. de C.V. Announces Final Results of its Exchange Offer
- OUTFRONT MEDIA APPOINTS GLOBAL MEDIA EXECUTIVE NICK BRIEN AS CEO AND BOLSTERS BOARD WITH MAGNITE'S MICHAEL BARRETT AND NETFLIX'S NICOLLE PANGIS
- Connexio Cloud, Leader in Business Communications Integration, Sets Deal With Decathlon Capital Partners For Growth Capital
- The Inner Circle acknowledges, Paolo Pelizzoli as a Pinnacle Professional Member Inner Circle of Excellence
- Whirlpool Corporation Declares Quarterly Dividend
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- Cobre del Mayo, S.A. de C.V. Announces Final Results of its Exchange Offer
- OUTFRONT MEDIA APPOINTS GLOBAL MEDIA EXECUTIVE NICK BRIEN AS CEO AND BOLSTERS BOARD WITH MAGNITE'S MICHAEL BARRETT AND NETFLIX'S NICOLLE PANGIS
- Connexio Cloud, Leader in Business Communications Integration, Sets Deal With Decathlon Capital Partners For Growth Capital
- The Inner Circle acknowledges, Paolo Pelizzoli as a Pinnacle Professional Member Inner Circle of Excellence
- Whirlpool Corporation Declares Quarterly Dividend